Status:
COMPLETED
Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study
Lead Sponsor:
IMDEA Food
Conditions:
Obesity
Overweight
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Non-communicable diseases (NCD) are the main health challenge in industrialized countries. However, these diseases are preventable if an intervention based on lifestyle is implemented at the populatio...
Detailed Description
The investigators propose a controlled, randomized, parallel groups intervention study based on nutritional counseling to reduce UPF consumption. Eligible participants are adults (18-50 years old), me...
Eligibility Criteria
Inclusion
- Men/women
- 18-50 years old
- BMI 25-40 Kg/m2
- UPF consumption \> 35% of total intake in g/day
Exclusion
- Pregnancy
- Menopause
- IMC \<25 Kg/m2 or \> 40 Kg/m2
- Excessive alcohol consumption
- Prevalent cardiovascular, renal, lung, pancreatic or liver disease
- Type 1 diabetes
- Type 2 diabetes with poor glucose control or unstable medication during last 3 months
- Prevalent endocrine disease
- Changes in anti-hypertensive medication during last 3 months
- Insulin, systemic anti-inflammatory, or glucocorticoid medication during last 3 months
- Food allergies or intolerances
- Psychosocial or cultural factors that prevent from following the intervention
Key Trial Info
Start Date :
June 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05319327
Start Date
June 6 2021
End Date
December 31 2022
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IMDEA Food
Madrid, Spain, 28049